Correlation Between China Molybdenum and Nanhua Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both China Molybdenum and Nanhua Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China Molybdenum and Nanhua Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between China Molybdenum Co and Nanhua Bio Medicine, you can compare the effects of market volatilities on China Molybdenum and Nanhua Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China Molybdenum with a short position of Nanhua Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of China Molybdenum and Nanhua Bio.

Diversification Opportunities for China Molybdenum and Nanhua Bio

0.46
  Correlation Coefficient

Very weak diversification

The 3 months correlation between China and Nanhua is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding China Molybdenum Co and Nanhua Bio Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nanhua Bio Medicine and China Molybdenum is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China Molybdenum Co are associated (or correlated) with Nanhua Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nanhua Bio Medicine has no effect on the direction of China Molybdenum i.e., China Molybdenum and Nanhua Bio go up and down completely randomly.

Pair Corralation between China Molybdenum and Nanhua Bio

Assuming the 90 days trading horizon China Molybdenum Co is expected to generate 0.6 times more return on investment than Nanhua Bio. However, China Molybdenum Co is 1.68 times less risky than Nanhua Bio. It trades about 0.07 of its potential returns per unit of risk. Nanhua Bio Medicine is currently generating about 0.01 per unit of risk. If you would invest  521.00  in China Molybdenum Co on August 26, 2024 and sell it today you would earn a total of  211.00  from holding China Molybdenum Co or generate 40.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

China Molybdenum Co  vs.  Nanhua Bio Medicine

 Performance 
       Timeline  
China Molybdenum 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days China Molybdenum Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, China Molybdenum is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Nanhua Bio Medicine 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Nanhua Bio Medicine are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nanhua Bio sustained solid returns over the last few months and may actually be approaching a breakup point.

China Molybdenum and Nanhua Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with China Molybdenum and Nanhua Bio

The main advantage of trading using opposite China Molybdenum and Nanhua Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China Molybdenum position performs unexpectedly, Nanhua Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nanhua Bio will offset losses from the drop in Nanhua Bio's long position.
The idea behind China Molybdenum Co and Nanhua Bio Medicine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Stocks Directory
Find actively traded stocks across global markets